Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Why is the price not going up?

<< Previous

Bullboard Posts

Next >>

Comment by mstrmndon Jun 01, 2020 10:33am

296 Views

Post# 31096082

RE:RE:RE:Why is the price not going up?

There's significant manipulation.

I've emailed Christina to send out an NR.

Totally doesn't make sense...other than scaring people to sell their shares, force weak hands out, so players behind the scenes can load up and make 3x within a week

Hideaway wrote: Mstrmnd, I also found the results great and picked up a few more at open. With over 8 mill. shares traded and price approaching .60 cents, the market obviously see it differently. What are we missing? As stated in an earlier post, the Company should intervene with some clarification. Just not making sense.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (May 24, 2024)